Neuroprotective effects of semaglutide targeting the left temporal lobe in adults with overweight or obesity: A 24‐week multimodal neuroimaging study
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Fanhua Meng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Obesity, Glucagon-Like Peptides, Overweight, Neuroprotective Agents. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Natural Science Research Funds of Minhang District, Shanghai, The Key Discipline Project of Shanghai Pudong New Area Health Commission, Shanghai Municipal Key Discipline.
Abstract (Originalsprache)
Background
Since obesity and its associated metabolic dysregulation are recognized risk factors for cognitive decline, this study investigated whether semaglutide, a glucagon‐like peptide‐1 receptor agonist proven to have cardiometabolic benefits, could provide potential neuroprotective effects on brain structure and function.
Methods
In a prospective, single‐arm intervention study, 26 adults with overweight or obesity received 1.0 mg semaglutide weekly for 24 weeks. Multimodal assessments were performed pre‐ and post‐intervention, including structural and functional MRI for analysing grey matter volume (GMV), fractional amplitude of low‐frequency fluctuations (fALFF), and regional homogeneity (ReHo). Cognitive function was evaluated using standardized computerized tasks (the Flanker and N‐back). Additionally, comprehensive metabolic profiles were assessed, including markers of glucose and lipid metabolism along with inflammatory cells.
Results
Semaglutide treatment significantly improved systemic metabolic health, inducing weight loss and reducing glycolipid levels and leukocyte counts. Neuroimaging revealed targeted neurobiological effects in the left temporal lobe: specifically, increased GMV in the left inferior temporal gyrus and decreased fALFF in the left middle and superior temporal gyri alongside reduced ReHo in the left middle temporal gyrus. These neural changes occurred despite no significant improvement in cognitive task performance. Importantly, the alterations in brain structure and function were not statistically correlated with the degree of weight loss or metabolic improvement.
Conclusions
A 24‐week semaglutide intervention induces significant neurobiological remodelling in the left temporal lobe of adults with overweight or obesity. These central effects are independent of the drug's systemic metabolic improvements, offering new evidence for its potential neuroprotective role.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
- Department of Laboratory Department, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
- Department of Endocrinology, Shanghai Fifth People's Hospital, Fudan University and Center of Community-Based Health Research, Fudan University, Shanghai, China.
- Department of Endocrinology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai, China.
ORCID-Profile: Shufei Zang, Tiange Sun
Förderung
- Natural Science Research Funds of Minhang District, Shanghai
- The Key Discipline Project of Shanghai Pudong New Area Health Commission
- Shanghai Municipal Key Discipline
- Shanghai Minhang District Health and Family Planning Commission Discipline Construction Project
Zitieren
APA
Meng, F., Ao, X., Lin, X., Li, Y., Zhang, R., Yu, Z., Zang, S., & Sun, T. (2026). Neuroprotective effects of semaglutide targeting the left temporal lobe in adults with overweight or obesity: A 24‐week multimodal neuroimaging study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70524
Vancouver
Meng F, Ao X, Lin X, Li Y, Zhang R, Yu Z, et al. Neuroprotective effects of semaglutide targeting the left temporal lobe in adults with overweight or obesity: A 24‐week multimodal neuroimaging study. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70524
BibTeX
@article{Meng2026,
author = {Meng, Fanhua and Ao, Xiang and Lin, Xiangming and Li, Yue and Zhang, Rui and Yu, Zhiyan and Zang, Shufei and Sun, Tiange},
title = {Neuroprotective effects of semaglutide targeting the left temporal lobe in adults with overweight or obesity: A 24‐week multimodal neuroimaging study},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70524}
}
EUVIMED